His primary areas of study are Transplantation, Kidney transplantation, Surgery, Internal medicine and Immunosuppression. His Transplantation research integrates issues from Congenital cytomegalovirus infection, Urology, Immunology and Renal function. His Kidney transplantation research incorporates themes from Sirolimus, Viral load, Creatinine, Prospective cohort study and Dialysis.
The concepts of his Surgery study are interwoven with issues in Kidney disease and Risk factor. His biological study spans a wide range of topics, including Gastroenterology and Diabetes mellitus. His Immunosuppression research is multidisciplinary, incorporating elements of Tacrolimus and Calcineurin.
His primary areas of investigation include Transplantation, Kidney transplantation, Surgery, Internal medicine and Immunology. The Transplantation study combines topics in areas such as Immunosuppression, Kidney, Kidney disease and Urology. Daniel C. Brennan has included themes like Creatinine, Proportional hazards model, Retrospective cohort study and Intensive care medicine in his Kidney transplantation study.
His research in Surgery intersects with topics in Urinary system and Risk factor. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Diabetes mellitus. His Immunology research includes elements of BK virus and Virology.
Daniel C. Brennan mostly deals with Kidney transplantation, Internal medicine, Intensive care medicine, Transplantation and Immunology. Kidney transplantation is the subject of his research, which falls under Surgery. His work in Surgery tackles topics such as Urology which are related to areas like Proteinuria and Solid organ.
His research in Intensive care medicine focuses on subjects like Medical prescription, which are connected to NARCOTIC USE, Anesthesia and Narcotic. His research integrates issues of Hypoglycemia and Virology in his study of Transplantation. His Immunology research incorporates themes from Calcineurin, Basiliximab and Thymoglobulin.
His main research concerns Kidney transplantation, Internal medicine, Intensive care medicine, Transplantation and Proportional hazards model. His research in Kidney transplantation intersects with topics in Finance, Allosensitization, Cause of death, Retrospective cohort study and Comorbidity. His Retrospective cohort study research is classified as research in Surgery.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. The various areas that Daniel C. Brennan examines in his Intensive care medicine study include Immunosuppression, NARCOTIC USE, Histocompatibility, Medical prescription and Kidney. His Transplantation study incorporates themes from Congenital cytomegalovirus infection, Cytomegalovirus infection and Letermovir.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International Trial of the Edmonton Protocol for Islet Transplantation
A. M James Shapiro;Camillo Ricordi;Bernhard J. Hering;Hugh Auchincloss.
The New England Journal of Medicine (2006)
Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations
Hans H. Hirsch;Daniel C. Brennan;Cinthia B. Drachenberg;Fabrizio Ginevri.
Identification of a novel polyomavirus from patients with acute respiratory tract infections.
Anne M Gaynor;Michael D Nissen;David M Whiley;Ian M Mackay.
PLOS Pathogens (2007)
Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
Daniel C. Brennan;John A. Daller;Kathleen D. Lake;Diane Cibrik.
The New England Journal of Medicine (2006)
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.
Daniel C. Brennan;Irfan Agha;Daniel L. Bohl;Mark A. Schnitzler.
American Journal of Transplantation (2005)
Delayed Graft Function in the Kidney Transplant
Andrew Siedlecki;William Irish;Daniel C. Brennan.
American Journal of Transplantation (2011)
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Francesco P. Schena;Michael D. Pascoe;Josefina Alberu;Maria del Carmen Rial.
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients.
Robert S. Woodward;Mark A. Schnitzler;Jack Baty;Jeffrey A. Lowell.
American Journal of Transplantation (2003)
A randomized, double-blinded comparison of thymoglobulin versus atgam for induction immunosuppressive therapy in adult renal transplant recipients
Daniel C. Brennan;Karen Flavin;Jeffrey A. Lowell;Todd K. Howard.
Incidence and Predictors of Myocardial Infarction after Kidney Transplantation
Krista L. Lentine;Daniel C. Brennan;Mark A. Schnitzler.
Journal of The American Society of Nephrology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: